Publications

75.Valle S., Alcalá S., Martin-Hijano L., Cabezas-Sainz P., Navarro D., Ramos Muñoz E., Yuste L., Tiwary K., Walter K., Alonso-Nocelo M., Rubiolo J.A., González-Arnay E., Garcia-Bermejo L., Hermann P.C., Sánchez L., Sancho P., Fernández-Moreno M.A., Sainz B. Jr.

Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells

Nat Commun. 2020 Oct 16; 11:5265

PMID: pending

IF 2019: 12.121

Q1 D1

74.Alcalá S, Mayoral-Varo V, Ruiz-Cañas L, López-Gil JC, Heeschen C, Martín-Pérez J, Sainz B Jr.

Targeting SRC Kinase Signaling in Pancreatic Cancer Stem Cells.

Int J Mol Sci. 2020 Oct 9;21(20):E7437.

PMID: 33050159

IF 2019: 4.556

73.Gout J, Perkhofer L, Morawe M, Arnold F, Ihle M, Biber S, Lange S, Roger E, Kraus JM, Stifter K, Hahn SA, Zamperone A, Engleitner T, Müller M, Walter K, Rodriguez-Aznar E, Sainz B Jr, Hermann PC, Hessmann E, Müller S, Azoitei N, Lechel A, Liebau S, Wagner M, Simeone DM, Kestler HA, Seufferlein T, Wiesmüller L, Rad R, Frappart PO, Kleger A.

Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.

Gut. 2020 Sep 1:gutjnl-2019-319970. doi: 10.1136/gutjnl-2019-319970. Online ahead of print.

PMID: 32873698

IF 2019: 19.819

Q1 D1

72.Cabezas-Sáinz P, Pensado-López A, Sáinz B Jr, Sánchez L.

Modeling Cancer Using Zebrafish Xenografts: Drawbacks for Mimicking the Human Microenvironment.

Cells. 2020 Aug 27;9(9):E1978.

PMID: 32867288

IF 2019: 4.366

71.Pajuelo-Lozano N, Alcalá S, Sainz B Jr*, Perona R*, Sanchez-Perez I*. (* corresponding)

Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines.

Theranostics. 2020 Jul 25;10(21):9601-9618.

PMID: 32863948

IF 2019: 8.579

Q1 D1

70.Cash TP, Alcalá S, Rico-Ferreira MDR, Hernández-Encinas E, García J, Albarrán MI, Valle S, Muñoz J, Martínez-González S, Blanco-Aparicio C, Pastor J, Serrano M, Sainz B Jr.

Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem Cells.

Cancers (Basel). 2020 Jul 4;12(7):E1790.

PMID: 32635473

IF 2019: 6.126

69.Alcalá S, Sancho P, Martinelli P, Navarro D, Pedrero C, Martín-Hijano L, Valle S, Earl J, Rodríguez-Serrano M, Ruiz-Cañas L, Rojas K, Carrato A, García-Bermejo L, Fernández-Moreno MÁ, Hermann PC, Sainz B Jr.

ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity.

Nat Commun. 2020 May 29;11(1):2682.

PMID: 32472071

IF 2019: 12.121

Q1 D1

68.Martin-Hijano L, Sainz B Jr.

The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway.

Front Immunol. 2020 Mar 31;11:526.

PMID: 32296435

IF 2019: 5.085

67.Frappart PO, Walter K, Gout J, Beutel AK, Morawe M, Arnold F, Breunig M, Barth TF, Marienfeld R, Schulte L, Ettrich T, Hackert T, Svinarenko M, Rösler R, Wiese S, Wiese H, Perkhofer L, Müller M, Lechel A, Sainz B Jr, Hermann PC, Seufferlein T, Kleger A.

Pancreatic cancer-derived organoids – a disease modeling tool to predict drug response.

United European Gastroenterol J. 2020 Jun;8(5):594-606.

PMID: 32213029

IF 2019: 3.549

66.Schulte LA, López-Gil JC, Sainz B Jr, Hermann PC.

The Cancer Stem Cell in Hepatocellular Carcinoma.

Cancers (Basel). 2020 Mar 14;12(3):684.

PMID: 32183251

IF 2019: 6.126

65.Lerma L, Muñoz AL, García Utrilla R, Sainz B Jr, Lim F, Tabarés E, Gómez-Sebastián S.

Partial complementation between the immediate early proteins ICP4 of herpes simplex virus type 1 and IE180 of pseudorabies virus.

Virus Res. 2020 Apr 2;279:197896.

PMID: 32045631

IF 2019: 2.934

64.Rodriguez-Aznar E, Wiesmüller L, Sainz B Jr, Hermann PC.

EMT and Stemness-Key Players in Pancreatic Cancer Stem Cells.

Cancers (Basel). 2019 Aug 8;11(8):1136.

PMID: 31398893

IF: 6.126

63.Walter K, Tiwary K, Trajkovic-Arsic M, Hidalgo-Sastre A, Dierichs L, Liffers ST, Gu J, Gout J, Schulte LA, Münch J, Seufferlein T, Sainz B Jr, Siveke JT, Rodriguez-Aznar E, Hermann PC.

MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo.

Stem Cells Int. 2019 Jun 2;2019:8475389.

PMID: 31281387

IF: 3.869

62.Alcalá S, Martinelli P, Hermann PC, Heeschen C, Sainz B Jr.

The Anthrax Toxin Receptor 1 (ANTXR1) Is Enriched in Pancreatic Cancer Stem Cells Derived from Primary Tumor Cultures.

Stem Cells Int. 2019 May 2;2019:1378639.

PMID: 31191663

IF: 3.869

61.Blasco MT, Navas C, Martín-Serrano G, Graña-Castro O, Lechuga CG, Martín-Díaz L, Djurec M, Li J, Morales-Cacho L, Esteban-Burgos L, Perales-Patón J, Bousquet-Mur E, Castellano E, Jacob HKC, Cabras L, Musteanu M, Drosten M, Ortega S, Mulero F, Sainz B Jr, Dusetti N, Iovanna J, Sánchez-Bueno F, Hidalgo M, Khiabanian H, Rabadán R, Al-Shahrour F, Guerra C, Barbacid M.

Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF.

Cancer Cell. 2019 Apr 15;35(4):573-587.e6.

PMID: 30975481

IF: 26.602

Q1 D1

60.D'Errico G, Alonso-Nocelo M, Vallespinos M, Hermann PC, Alcalá S, García CP, Martin-Hijano L, Valle S, Earl J, Cassiano C, Lombardia L, Feliu J, Monti MC, Seufferlein T, García-Bermejo L, Martinelli P, Carrato A, Sainz B Jr.

Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance.

Oncogene. 2019 Jul;38(27):5469-5485.

PMID: 30936462

IF: 7.971

Q1 D1

59.Alcalá S, Sainz B Jr.

The dark side of radiotherapy-induced cell death in cancer.

EBioMedicine. 2019 Feb;40:7-8.

PMID: 30704926

IF: 5.736

58.González I, Earl J, Fernández LJ, Sainz B, Pinto A, Monge R, Alcalá S, Castillejo A, Soto JL, Carrato A.

A Label Free Disposable Device for Rapid Isolation of Rare Tumor Cells from Blood by Ultrasounds.

Micromachines (Basel). 2018 Mar 15;9(3):129.

PMID: 30424062

IF: 2.426

57.Görgülü K, Diakopoulos KN, Ai J, Schoeps B, Kabacaoglu D, Karpathaki AF, Ciecielski KJ, Kaya-Aksoy E, Ruess DA, Berninger A, Kowalska M, Stevanovic M, Wörmann SM, Wartmann T, Zhao Y, Halangk W, Voronina S, Tepikin A, Schlitter AM, Steiger K, Artati A, Adamski J, Aichler M, Walch A, Jastroch M, Hartleben G, Mantzoros CS, Weichert W, Schmid RM, Herzig S, Krüger A, Sainz B Jr, Lesina M, Algül H.

Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice.

Gastroenterology. 2019 Jan;156(1):203-217.e20.

PMID: 30296435

IF: 17.373

Q1 D1

56.Friederich MW, Timal S, Powell CA, Dallabona C, Kurolap A, Palacios-Zambrano S, Bratkovic D, Derks TGJ, Bick D, Bouman K, Chatfield KC, Damouny-Naoum N, Dishop MK, Falik-Zaccai TC, Fares F, Fedida A, Ferrero I, Gallagher RC, Garesse R, Gilberti M, González C, Gowan K, Habib C, Halligan RK, Kalfon L, Knight K, Lefeber D, Mamblona L, Mandel H, Mory A, Ottoson J, Paperna T, Pruijn GJM, Rebelo-Guiomar PF, Saada A, Sainz B Jr, Salvemini H, Schoots MH, Smeitink JA, Szukszto MJ, Ter Horst HJ, van den Brandt F, van Spronsen FJ, Veltman JA, Wartchow E, Wintjes LT, Zohar Y, Fernández-Moreno MA, Baris HN, Donnini C, Minczuk M, Rodenburg RJ, Van Hove JLK.

Pathogenic variants in glutamyl-tRNAGln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder.

Nat Commun. 2018 Oct 3;9(1):4065.

PMID: 30283131

IF: 11.878

Q1 D1

55.Hermann PC, Sainz B Jr.

Pancreatic cancer stem cells: A state or an entity?

Semin Cancer Biol. 2018 Dec;53:223-231.

PMID: 30130664

IF: 9.658

Q1 D1

54.Zagorac S, Garcia-Bermejo L, Sainz B Jr

The Epigenetic Landscape of Pancreatic Cancer Stem Cells.

Epigenomes 2018, 2(2), 10

PMID: 4655/2/2/10

n/a

53.Ruess DA, Heynen GJ, Ciecielski KJ, Ai J, Berninger A, Kabacaoglu D, Görgülü K, Dantes Z, Wörmann SM, Diakopoulos KN, Karpathaki AF, Kowalska M, Kaya-Aksoy E, Song L, van der Laan EAZ, López-Alberca MP, Nazaré M, Reichert M, Saur D, Erkan MM, Hopt UT, Sainz B Jr, Birchmeier W, Schmid RM, Lesina M, Algül H.

Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase.

Nat Med. 2018 Jul;24(7):954-960.

PMID: 29808009

IF: 30.641

Q1 D1

52.Alguacil-Núñez C, Ferrer-Ortiz I, García-Verdú E, López-Pirez P, Llorente-Cortijo IM, Sainz B Jr.

Current perspectives on the crosstalk between lung cancer stem cells and cancer-associated fibroblasts.

Crit Rev Oncol Hematol. 2018 May;125:102-110.

PMID: 29650269

IF: 5.012

51.Djurec M, Graña O, Lee A, Troulé K, Espinet E, Cabras L, Navas C, Blasco MT, Martín-Díaz L, Burdiel M, Li J, Liu Z, Vallespinós M, Sanchez-Bueno F, Sprick MR, Trumpp A, Sainz B Jr, Al-Shahrour F, Rabadan R, Guerra C, Barbacid M.

Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.

Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1147-E1156.

PMID: 29351990

IF: 9.580

Q1 D1

50.Valle S, Martin-Hijano L, Alcalá S, Alonso-Nocelo M, Sainz B Jr.

The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer.

Cancers (Basel). 2018 Jan 26;10(2):33.

PMID: 29373514

IF: 6.161

49.D'Errico G, Machado HL, Sainz B Jr.

A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet.

Clin Transl Med. 2017 Dec;6(1):3.

PMID: 28050779

0.700

48.Martinelli P, Carrillo-de Santa Pau E, Cox T, Sainz B Jr, Dusetti N, Greenhalf W, Rinaldi L, Costello E, Ghaneh P, Malats N, Büchler M, Pajic M, Biankin AV, Iovanna J, Neoptolemos J, Real FX.

GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer.

Gut. 2017 Sep;66(9):1665-1676.

PMID: 27325420

IF: 16.658

Q1 D1

47.da Silva IL, Montero-Montero L, Martín-Villar E, Martin-Pérez J, Sainz B, Renart J, Toscano Simões R, Soares Veloso É, Salviano Teixeira C, de Oliveira MC, Ferreira E, Quintanilla M.

Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cells.

Sci Rep. 2017 Jul 24;7(1):6276.

PMID: 28740236

IF: 4.122

46.Hohwieler M, Illing A, Hermann PC, Mayer T, Stockmann M, Perkhofer L, Eiseler T, Antony JS, Müller M, Renz S, Kuo CC, Lin Q, Sendler M, Breunig M, Kleiderman SM, Lechel A, Zenker M, Leichsenring M, Rosendahl J, Zenke M, Sainz B Jr, Mayerle J, Costa IG, Seufferlein T, Kormann M, Wagner M, Liebau S, Kleger A.

Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling.

Gut. 2017 Mar;66(3):473-486.

PMID: 27633923

IF: 16.658

Q1 D1

45.Hann A, Sainz B Jr, Hermann PC

The metastatic niche in the liver: tilling the soil for pancreatic cancer progression.

Translational Cancer Research. Feb 2017, 6 (1), S217-S220.

PMID: 12244

n/a

44.López-Gómez M, Casado E, Muñoz M, Alcalá S, Moreno-Rubio J, D'Errico G, Jiménez-Gordo AM, Salinas S, Sainz B Jr.

Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives.

Crit Rev Oncol Hematol. 2016 Nov;107:54-71.

PMID: 27823652

IF: 4.971

43.Zagorac S, Alcala S, Fernandez Bayon G, Bou Kheir T, Schoenhals M, González-Neira A, Fernandez Fraga M, Aicher A, Heeschen C, Sainz B Jr.

DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster.

Cancer Res. 2016 Aug 1;76(15):4546-58.

PMID: 27261509

IF: 9.122

Q1 D1

42.Sancho P, Alcala S, Usachov V, Hermann PC, Sainz B Jr.

The ever-changing landscape of pancreatic cancer stem cells.

Pancreatology. 2016 Jul-Aug;16(4):489-96.

PMID: 27161173

IF: 2.580

41.Sainz B Jr, Carron E, Vallespinós M, Machado HL.

Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies.

Mediators Inflamm. 2016;2016:9012369.

PMID: 26980947

IF: 3.232

40.Lerma L, Alcalá S, Piñero C, Torres M, Martin B, Lim F, Sainz B Jr, Tabarés E.

Expression of the immediate early IE180 protein under the control of the hTERT and CEA tumor-specific promoters in recombinant pseudorabies viruses: Effects of IE180 protein on promoter activity and apoptosis induction.

Virology. 2016 Jan 15;488:9-19.

PMID: 26590793

IF: 3.353

39.Sancho P, Burgos-Ramos E, Tavera A, Bou Kheir T, Jagust P, Schoenhals M, Barneda D, Sellers K, Campos-Olivas R, Graña O, Viera CR, Yuneva M, Sainz B Jr, Heeschen C.

MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.

Cell Metab. 2015 Oct 6;22(4):590-605.

PMID: 26365176

IF: 17.303

Q1 D1

38.Cioffi M, Trabulo SM, Sanchez-Ripoll Y, Miranda-Lorenzo I, Lonardo E, Dorado J, Reis Vieira C, Ramirez JC, Hidalgo M, Aicher A, Hahn S, Sainz B Jr, Heeschen C.

The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.

Gut. 2015 Dec;64(12):1936-48.

PMID: 25887381

IF: 14.921

Q1 D1

37.Sainz B Jr*, Alcala S, Garcia E, Sanchez-Ripoll Y, Azevedo MM, Cioffi M, Tatari M, Miranda-Lorenzo I, Hidalgo M, Gomez-Lopez G, Cañamero M, Erkan M, Kleeff J, García-Silva S, Sancho P, Hermann PC, Heeschen C.* (* corresponding)

Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment.

Gut. 2015 Dec;64(12):1921-35.

PMID: 25841238

IF: 14.921

Q1 D1

36.Sainz B Jr, Miranda-Lorenzo I, Heeschen C.

The fuss over lipofuscin: not all autofluorescence is the same.

Eur J Histochem. 2015 Mar 12;59(1):2512.

PMID: 25820568

IF: 2.421

35.Sainz B Jr*, Martín B, Tatari M, Heeschen C, Guerra S.* (* corresponding)

ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells.

Cancer Res. 2014 Dec 15;74(24):7309-20.

PMID: 25368022

IF: 9.329

Q1 D1

34.Uprichard SL, Sainz B Jr.

Inhibition of hepatitis C entry: too soon to dismiss while many are still being denied treatment.

Gut. 2015 Apr;64(4):690-1.

PMID: 25287483

IF: 14.921

Q1 D1

33.Miranda-Lorenzo I, Dorado J, Lonardo E, Alcala S, Serrano AG, Clausell-Tormos J, Cioffi M, Megias D, Zagorac S, Balic A, Hidalgo M, Erkan M, Kleeff J, Scarpa A, Sainz B Jr*, Heeschen C.* (* corresponding)

Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.

Nat Methods. 2014 Nov;11(11):1161-9.

PMID: 25262208

IF: 32.072

Q1 D1

32.Hermann PC, Sancho P, Cañamero M, Martinelli P, Madriles F, Michl P, Gress T, de Pascual R, Gandia L, Guerra C, Barbacid M, Wagner M, Vieira CR, Aicher A, Real FX, Sainz B Jr*, Heeschen C.* (* corresponding)

Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.

Gastroenterology. 2014 Nov;147(5):1119-33.e4.

PMID: 25127677

IF: 16.716

Q1 D1

31.Balic A, Sørensen MD, Trabulo SM, Sainz B Jr, Cioffi M, Vieira CR, Miranda-Lorenzo I, Hidalgo M, Kleeff J, Erkan M, Heeschen C.

Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling.

Mol Cancer Ther. 2014 Jul;13(7):1758-71.

PMID: 24785258

IF: 5.683

30.Royo S, Sainz B Jr, Hernández-Jiménez E, Reyburn H, López-Collazo E, Guerra S.

Differential induction of apoptosis, interferon signaling, and phagocytosis in macrophages infected with a panel of attenuated and nonattenuated poxviruses.

J Virol. 2014 May;88(10):5511-23.

PMID: 24599993

IF: 4.439

29.Barretto N, Sainz B Jr, Hussain S, Uprichard SL.

Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread.

J Virol. 2014 May;88(9):5050-61.

PMID: 24554660

IF: 4.439

28.Hermann PC, Trabulo SM, Sainz B Jr, Balic A, Garcia E, Hahn SA, Vandana M, Sahoo SK, Tunici P, Bakker A, Hidalgo M, Heeschen C.

Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts.

PLoS One. 2013 Jun 18;8(6):e66371.

PMID: 23825539

IF: 3.534

27.Sainz B Jr, Heeschen C.

Standing out from the crowd: cancer stem cells in hepatocellular carcinoma

Cancer Cell. 2013 Apr 15;23(4):431-3.

PMID: 23597561

IF: 23.893

Q1 D1

26.Yu X, Sainz B Jr, Petukhov PA, Uprichard SL.

Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay.

Antimicrob Agents Chemother. 2012 Dec;56(12):6109-20

PMID: 22948883

IF: 4.565

25.Sainz B Jr, Barretto N, Yu X, Corcoran P, Uprichard SL.

Permissiveness of human hepatoma cell lines for HCV infection.

Virol J. 2012 Jan 24;9:30.

PMID: 22273112

IF: 2.092

24.Sainz B Jr*, Barretto N, Martin DN, Hiraga N, Imamura M, Hussain S, Marsh KA, Yu X, Chayama K, Alrefai WA, Uprichard SL.* (* corresponding)

Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor.

Nat Med. 2012 Jan 8;18(2):281-5.

PMID: 22231557

IF: 24.302

Q1 D1

23.Tencate V, Sainz B Jr, Cotler SJ, Uprichard SL.

Potential treatment options and future research to increase hepatitis C virus treatment response rate.

Hepat Med. 2010 Oct;2010(2):125-145.

PMID: 21331152

IF: n/a

22.Sainz B Jr, Barretto N, Uprichard SL.

Hepatitis C virus infection in phenotypically distinct Huh7 cell lines.

PLoS One. 2009 Aug 10;4(8):e6561.

PMID: 19668344

IF: 4.351

21.Yu X, Sainz B Jr, Uprichard SL.

Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening.

Antimicrob Agents Chemother. 2009 Oct;53(10):4311-9.

PMID: 19620334

IF: 4.802

20.Sainz B Jr, TenCate V, Uprichard SL.

Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection.

Virol J. 2009 Jul 15;6:103.

PMID: 19604376

IF: 2.435

19.Li L, Oropeza CE, Sainz B Jr, Uprichard SL, Gonzalez FJ, McLachlan A.

Developmental regulation of hepatitis B virus biosynthesis by hepatocyte nuclear factor 4alpha.

PLoS One. 2009;4(5):e5489.

PMID: 19424486

IF: 4.351

18.Dahari H*, Sainz B Jr*, Perelson AS, Uprichard SL. (*co-first)

Modeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferon.

J Virol. 2009 Jul;83(13):6383-90.

PMID: 19369346

IF: 5.150

17.Choi S, Sainz B Jr, Corcoran P, Uprichard S, Jeong H.

Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells.

Xenobiotica. 2009 Mar;39(3):205-17.

PMID: 19280519

IF: 2.799

16.Winer KK, Sinaii N, Peterson D, Sainz B Jr, Cutler GB Jr.

Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism.

J Clin Endocrinol Metab. 2008 Sep;93(9):3389-95.

PMID: 18492754

IF: 6.325

15.Colmegna I, Sainz B Jr, Citera G, Maldonado-Cocco JA, Garry RF, Espinoza LR.

Anti-20S proteasome antibodies in psoriatic arthritis.

J Rheumatol. 2008 Apr;35(4):674-6.

PMID: 18278835

IF: 3.282

14.Mossel EC, Sainz B Jr, Garry RF, Peters CJ.

Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN.

Adv Exp Med Biol. 2006;581:503-6.

PMID: 17037585

IF: 0.646

13.Sainz B Jr, Chisari FV.

Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells.

J Virol. 2006 Oct;80(20):10253-7.

PMID: 17005703

IF: 5.341

12.Sainz B Jr*, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. (* corresponding)

Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.

Virus Res. 2006 Sep;120(1-2):146-55.

PMID: 16616792

IF: 2.562

11.Colmegna I, Sainz B Jr, Garry RF, Espinoza LR.

The proteasome and its implications in rheumatology.

J Rheumatol. 2005 Jul;32(7):1192-8.

PMID: 15996052

IF: 3.010

10.Sainz B Jr, Rausch JM, Gallaher WR, Garry RF, Wimley WC.

Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein.

J Virol. 2005 Jun;79(11):7195-206.

PMID: 15890958

IF: 5.178

9.Sainz B Jr, LaMarca HL, Garry RF, Morris CA.

Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma.

Virol J. 2005 Feb 23;2:14.

PMID: 15727684

IF: n/a

8.Sainz B Jr, Rausch JM, Gallaher WR, Garry RF, Wimley WC.

The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry.

Biochemistry. 2005 Jan 25;44(3):947-58.

PMID: 15654751

IF: 3.848

7.LaMarca HL, Sainz B Jr, Morris CA.

Permissive human cytomegalovirus infection of a first trimester extravillous cytotrophoblast cell line.

Virol J. 2004 Nov 17;1:8.

PMID: 15548334

IF: n/a

6.Sainz B Jr, Mossel EC, Peters CJ, Garry RF.

Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

Virology. 2004 Nov 10;329(1):11-7.

PMID: 15476870

IF: 3.71

5.Sainz B Jr, Halford WP.

Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1.

J Virol. 2002 Nov;76(22):11541-50.

PMID: 12388715

IF: 5.241

Q1 D1

4.Härle P, Sainz B Jr, Carr DJ, Halford WP.

The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.

Virology. 2002 Feb 15;293(2):295-304.

PMID: 11886249

IF: 3.363

3.Loutsch JM, Sainz B Jr, Marquart ME, Zheng X, Kesavan P, Higaki S, Hill JM, Tal-Singer R.

Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.

Antimicrob Agents Chemother. 2001 Jul;45(7):2044-53.

PMID: 11408221

IF: 4.562

Q1 D1

2.Sainz B, Loutsch JM, Marquart ME, Hill JM.

Stress-associated immunomodulation and herpes simplex virus infections.

Med Hypotheses. 2001 Mar;56(3):348-56.

PMID: 11359358

IF: 0.745

1.Zheng X, Marquart ME, Loustch JM, Shah P, Sainz B, Ray A, O'Callaghan RJ, Kaufman HE, Hill JM.

HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.

Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2490-7.

PMID: 10509641

IF: 4.858

Q1 D1